The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Developing Platforms by Artificial Intelligence (AI) Market Research Report 2024
Synopsis
Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process.
The global Drug Developing Platforms by Artificial Intelligence (AI) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Developing Platforms by Artificial Intelligence (AI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Developing Platforms by Artificial Intelligence (AI).
Report Scope
The Drug Developing Platforms by Artificial Intelligence (AI) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Developing Platforms by Artificial Intelligence (AI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Developing Platforms by Artificial Intelligence (AI) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antidote
Atomwise
Turbine
Cambridge Cancer Genomics
Row Analytics
Deep Genomics
Insilico Medicine
IBM
Microsoft
Google
AiCure
Calico
Iktos
GNS Healthcare
Genpact
Biovista
NuMedii
BenevolentAI
BERG
Schrödinge
Nuritas
Exscientia
Kairntech
Concerto HealthAI (SymphonyAI)
NVIDIA Corporation
Sirenas
Standigm
Transcriptic
Cloud Pharmaceuticals
Cyclica
Segment by Type
Software
System
Service
Product
Others
Segment by Application
Generate Data and Models
Repurpose Existing Drugs
Generate Novel Drug Candidates
Validate and Optimize Drug Candidates
Design Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Developing Platforms by Artificial Intelligence (AI) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process.
The global Drug Developing Platforms by Artificial Intelligence (AI) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Developing Platforms by Artificial Intelligence (AI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Developing Platforms by Artificial Intelligence (AI).
Report Scope
The Drug Developing Platforms by Artificial Intelligence (AI) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Developing Platforms by Artificial Intelligence (AI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Developing Platforms by Artificial Intelligence (AI) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antidote
Atomwise
Turbine
Cambridge Cancer Genomics
Row Analytics
Deep Genomics
Insilico Medicine
IBM
Microsoft
AiCure
Calico
Iktos
GNS Healthcare
Genpact
Biovista
NuMedii
BenevolentAI
BERG
Schrödinge
Nuritas
Exscientia
Kairntech
Concerto HealthAI (SymphonyAI)
NVIDIA Corporation
Sirenas
Standigm
Transcriptic
Cloud Pharmaceuticals
Cyclica
Segment by Type
Software
System
Service
Product
Others
Segment by Application
Generate Data and Models
Repurpose Existing Drugs
Generate Novel Drug Candidates
Validate and Optimize Drug Candidates
Design Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Developing Platforms by Artificial Intelligence (AI) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 System
1.2.4 Service
1.2.5 Product
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Generate Data and Models
1.3.3 Repurpose Existing Drugs
1.3.4 Generate Novel Drug Candidates
1.3.5 Validate and Optimize Drug Candidates
1.3.6 Design Drugs
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Perspective (2019-2030)
2.2 Drug Developing Platforms by Artificial Intelligence (AI) Growth Trends by Region
2.2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Region (2019-2024)
2.2.3 Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Region (2025-2030)
2.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Dynamics
2.3.1 Drug Developing Platforms by Artificial Intelligence (AI) Industry Trends
2.3.2 Drug Developing Platforms by Artificial Intelligence (AI) Market Drivers
2.3.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Challenges
2.3.4 Drug Developing Platforms by Artificial Intelligence (AI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Developing Platforms by Artificial Intelligence (AI) Players by Revenue
3.1.1 Global Top Drug Developing Platforms by Artificial Intelligence (AI) Players by Revenue (2019-2024)
3.1.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Players (2019-2024)
3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Developing Platforms by Artificial Intelligence (AI) Revenue
3.4 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio
3.4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Developing Platforms by Artificial Intelligence (AI) Revenue in 2023
3.5 Drug Developing Platforms by Artificial Intelligence (AI) Key Players Head office and Area Served
3.6 Key Players Drug Developing Platforms by Artificial Intelligence (AI) Product Solution and Service
3.7 Date of Enter into Drug Developing Platforms by Artificial Intelligence (AI) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Developing Platforms by Artificial Intelligence (AI) Breakdown Data by Type
4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Type (2019-2024)
4.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Type (2025-2030)
5 Drug Developing Platforms by Artificial Intelligence (AI) Breakdown Data by Application
5.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Application (2019-2024)
5.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2019-2030)
6.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2019-2024)
6.4 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2019-2030)
7.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2019-2024)
7.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2019-2030)
8.2 Asia-Pacific Drug Developing Platforms by Artificial Intelligence (AI) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2019-2030)
9.2 Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2019-2024)
9.4 Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2019-2030)
10.2 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Antidote
11.1.1 Antidote Company Detail
11.1.2 Antidote Business Overview
11.1.3 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.1.4 Antidote Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.1.5 Antidote Recent Development
11.2 Atomwise
11.2.1 Atomwise Company Detail
11.2.2 Atomwise Business Overview
11.2.3 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.2.4 Atomwise Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.2.5 Atomwise Recent Development
11.3 Turbine
11.3.1 Turbine Company Detail
11.3.2 Turbine Business Overview
11.3.3 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.3.4 Turbine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.3.5 Turbine Recent Development
11.4 Cambridge Cancer Genomics
11.4.1 Cambridge Cancer Genomics Company Detail
11.4.2 Cambridge Cancer Genomics Business Overview
11.4.3 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.4.4 Cambridge Cancer Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.4.5 Cambridge Cancer Genomics Recent Development
11.5 Row Analytics
11.5.1 Row Analytics Company Detail
11.5.2 Row Analytics Business Overview
11.5.3 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.5.4 Row Analytics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.5.5 Row Analytics Recent Development
11.6 Deep Genomics
11.6.1 Deep Genomics Company Detail
11.6.2 Deep Genomics Business Overview
11.6.3 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.6.4 Deep Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.6.5 Deep Genomics Recent Development
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Detail
11.7.2 Insilico Medicine Business Overview
11.7.3 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.7.4 Insilico Medicine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.7.5 Insilico Medicine Recent Development
11.8 IBM
11.8.1 IBM Company Detail
11.8.2 IBM Business Overview
11.8.3 IBM Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.8.4 IBM Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.8.5 IBM Recent Development
11.9 Microsoft
11.9.1 Microsoft Company Detail
11.9.2 Microsoft Business Overview
11.9.3 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.9.4 Microsoft Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.9.5 Microsoft Recent Development
11.10 Google
11.10.1 Google Company Detail
11.10.2 Google Business Overview
11.10.3 Google Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.10.4 Google Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.10.5 Google Recent Development
11.11 AiCure
11.11.1 AiCure Company Detail
11.11.2 AiCure Business Overview
11.11.3 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.11.4 AiCure Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.11.5 AiCure Recent Development
11.12 Calico
11.12.1 Calico Company Detail
11.12.2 Calico Business Overview
11.12.3 Calico Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.12.4 Calico Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.12.5 Calico Recent Development
11.13 Iktos
11.13.1 Iktos Company Detail
11.13.2 Iktos Business Overview
11.13.3 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.13.4 Iktos Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.13.5 Iktos Recent Development
11.14 GNS Healthcare
11.14.1 GNS Healthcare Company Detail
11.14.2 GNS Healthcare Business Overview
11.14.3 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.14.4 GNS Healthcare Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.14.5 GNS Healthcare Recent Development
11.15 Genpact
11.15.1 Genpact Company Detail
11.15.2 Genpact Business Overview
11.15.3 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.15.4 Genpact Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.15.5 Genpact Recent Development
11.16 Biovista
11.16.1 Biovista Company Detail
11.16.2 Biovista Business Overview
11.16.3 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.16.4 Biovista Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.16.5 Biovista Recent Development
11.17 NuMedii
11.17.1 NuMedii Company Detail
11.17.2 NuMedii Business Overview
11.17.3 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.17.4 NuMedii Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.17.5 NuMedii Recent Development
11.18 BenevolentAI
11.18.1 BenevolentAI Company Detail
11.18.2 BenevolentAI Business Overview
11.18.3 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.18.4 BenevolentAI Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.18.5 BenevolentAI Recent Development
11.19 BERG
11.19.1 BERG Company Detail
11.19.2 BERG Business Overview
11.19.3 BERG Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.19.4 BERG Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.19.5 BERG Recent Development
11.20 Schrödinge
11.20.1 Schrödinge Company Detail
11.20.2 Schrödinge Business Overview
11.20.3 Schrödinge Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.20.4 Schrödinge Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.20.5 Schrödinge Recent Development
11.21 Nuritas
11.21.1 Nuritas Company Detail
11.21.2 Nuritas Business Overview
11.21.3 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.21.4 Nuritas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.21.5 Nuritas Recent Development
11.22 Exscientia
11.22.1 Exscientia Company Detail
11.22.2 Exscientia Business Overview
11.22.3 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.22.4 Exscientia Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.22.5 Exscientia Recent Development
11.23 Kairntech
11.23.1 Kairntech Company Detail
11.23.2 Kairntech Business Overview
11.23.3 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.23.4 Kairntech Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.23.5 Kairntech Recent Development
11.24 Concerto HealthAI (SymphonyAI)
11.24.1 Concerto HealthAI (SymphonyAI) Company Detail
11.24.2 Concerto HealthAI (SymphonyAI) Business Overview
11.24.3 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.24.4 Concerto HealthAI (SymphonyAI) Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.24.5 Concerto HealthAI (SymphonyAI) Recent Development
11.25 NVIDIA Corporation
11.25.1 NVIDIA Corporation Company Detail
11.25.2 NVIDIA Corporation Business Overview
11.25.3 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.25.4 NVIDIA Corporation Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.25.5 NVIDIA Corporation Recent Development
11.26 Sirenas
11.26.1 Sirenas Company Detail
11.26.2 Sirenas Business Overview
11.26.3 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.26.4 Sirenas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.26.5 Sirenas Recent Development
11.27 Standigm
11.27.1 Standigm Company Detail
11.27.2 Standigm Business Overview
11.27.3 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.27.4 Standigm Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.27.5 Standigm Recent Development
11.28 Transcriptic
11.28.1 Transcriptic Company Detail
11.28.2 Transcriptic Business Overview
11.28.3 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.28.4 Transcriptic Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.28.5 Transcriptic Recent Development
11.29 Cloud Pharmaceuticals
11.29.1 Cloud Pharmaceuticals Company Detail
11.29.2 Cloud Pharmaceuticals Business Overview
11.29.3 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.29.4 Cloud Pharmaceuticals Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.29.5 Cloud Pharmaceuticals Recent Development
11.30 Cyclica
11.30.1 Cyclica Company Detail
11.30.2 Cyclica Business Overview
11.30.3 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.30.4 Cyclica Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2019-2024)
11.30.5 Cyclica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
